Bradway A. Robert's Insider Trades & SAST Disclosures
Bradway A. Robert's most recent trade in AMGEN Inc. was a trade of 12,853 Common Stock done at an average price of $313.7 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bradway A. Robert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.71 per share. | 17 Mar 2025 | 12,853 | 587,565 (0%) | 0% | 313.7 | 4,032,115 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,734 | 599,925 (0%) | 0% | 0 | Common Stock | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 508 | 13,682 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Bradway A. Robert | Director, Chairman, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2024 | 96,000 | 573,855 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | A. Robert Bradway | Director, Chairman, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2024 | 90,000 | 90,000 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Bradway Robert A. | Director, Chairman, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2024 | 90,000 | 393,855 (0%) | 0% | 0 | Common Stock | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 580 | 13,173 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 479 | 12,593 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 77,877 | 77,877 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 11,988 | 669,269 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.29 per share. | 05 May 2024 | 2,220 | 657,281 (0%) | 0% | 311.3 | 691,064 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.37 per share. | 02 May 2024 | 2,294 | 659,501 (0%) | 0% | 277.4 | 636,287 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.38 per share. | 30 Apr 2024 | 2,282 | 661,795 (0%) | 0% | 276.4 | 630,699 | Common Stock |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 464 | 12,113 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 268.87 per share. | 18 Mar 2024 | 20,560 | 664,077 (0%) | 0% | 268.9 | 5,527,967 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 41,133 | 683,910 (0%) | 0% | 0 | Common Stock | |
| Boeing Co. | Bradway A. Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 348 | 11,648 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 467 | 11,300 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 420 | 10,832 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.89 per share. | 05 May 2023 | 2,083 | 641,734 (0%) | 0% | 231.9 | 483,027 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 114,040 | 114,040 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 13,486 | 646,680 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.97 per share. | 02 May 2023 | 2,863 | 643,817 (0%) | 0% | 236.0 | 675,582 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.74 per share. | 30 Apr 2023 | 2,208 | 633,194 (0%) | 0% | 239.7 | 529,346 | Common Stock |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 411 | 10,412 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 234.57 per share. | 17 Mar 2023 | 13,971 | 635,402 (0%) | 0% | 234.6 | 3,277,177 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 27,915 | 648,712 (0%) | 0% | 0 | Common Stock | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 455 | 10,000 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 715 | 9,544 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 640 | 8,829 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.10 per share. | 05 May 2022 | 2,017 | 619,841 (0%) | 0% | 236.1 | 476,214 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 112,508 | 112,508 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 13,781 | 624,550 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.92 per share. | 02 May 2022 | 2,692 | 621,858 (0%) | 0% | 230.9 | 621,637 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 249.87 per share. | 27 Apr 2022 | 2,547 | 610,769 (0%) | 0% | 249.9 | 636,419 | Common Stock |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 465 | 8,189 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.86 per share. | 18 Mar 2022 | 17,481 | 613,316 (0%) | 0% | 235.9 | 4,123,069 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 34,964 | 630,141 (0%) | 0% | 0 | Common Stock | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 428 | 7,723 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 396 | 7,294 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 385 | 6,898 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 115,307 | 115,307 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 13,280 | 599,925 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.64 per share. | 30 Apr 2021 | 2,902 | 597,023 (0%) | 0% | 239.6 | 695,435 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.64 per share. | 30 Apr 2021 | 2,850 | 594,173 (0%) | 0% | 239.6 | 682,974 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 255.52 per share. | 27 Apr 2021 | 2,617 | 586,645 (0%) | 0% | 255.5 | 668,696 | Common Stock |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 328 | 6,512 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.42 per share. | 19 Mar 2021 | 21,190 | 589,262 (0%) | 0% | 244.4 | 5,179,260 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 38,953 | 609,806 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.69 per share. | 18 Feb 2021 | 73,500 | 618,380 (0%) | 0% | 54.7 | 4,019,715 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2021 | 73,500 | 0 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.61 per share. | 18 Feb 2021 | 47,527 | 570,853 (0%) | 0% | 235.6 | 11,197,836 | Common Stock |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 405 | 6,183 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 495 | 5,777 | - | - | Phantom Stock Units | |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 451 | 5,282 | - | - | Phantom Stock Units | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 102,031 | 102,031 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2020 | 12,184 | 543,966 (0%) | 0% | 0 | Common Stock | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.98 per share. | 01 May 2020 | 2,759 | 531,782 (0%) | 0% | 231.0 | 637,274 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.22 per share. | 01 May 2020 | 2,737 | 534,541 (0%) | 0% | 239.2 | 654,745 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.28 per share. | 27 Apr 2020 | 2,543 | 537,278 (0%) | 0% | 236.3 | 600,860 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2020 | 84,000 | 0 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.43 per share. | 13 Apr 2020 | 84,000 | 595,516 (0%) | 0% | 58.4 | 4,908,120 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 218.21 per share. | 13 Apr 2020 | 55,695 | 539,821 (0%) | 0% | 218.2 | 12,153,206 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.43 per share. | 13 Apr 2020 | 43,000 | 540,027 (0%) | 0% | 58.4 | 2,512,490 | Common Stock |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2020 | 43,000 | 0 | - | - | Nqso (Right to Buy) | |
| AMGEN Inc. | Robert A. Bradway | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 218.21 per share. | 13 Apr 2020 | 28,511 | 511,516 (0%) | 0% | 218.2 | 6,221,385 | Common Stock |
| Boeing Co. | Robert A. Bradway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 610 | 4,830 | - | - | Phantom Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges